NOMAD: Non-locking, stOchastic Multi-machine algorithm for Asynchronous and Decentralized matrix completion

We develop an efficient parallel distributed algorithm for matrix completion, named NOMAD (Non-locking, stOchastic Multi-machine algorithm for Asynchronous and Decentralized matrix completion). NOMAD is a decentralized algorithm with non-blocking communication between processors. One of the key features of NOMAD is that the ownership of a variable is asynchronously transferred between processors in a decentralized fashion. As a consequence it is a lock-free parallel algorithm. In spite of being an asynchronous algorithm, the variable updates of NOMAD are serializable, that is, there is an equivalent update ordering in a serial implementation. NOMAD outperforms synchronous algorithms which require explicit bulk synchronization after every iteration: our extensive empirical evaluation shows that not only does our algorithm perform well in distributed setting on commodity hardware, but also outperforms state-of-the-art algorithms on a HPC cluster both in multi-core and distributed memory settings

UniquID: A Quest to Reconcile Identity Access Management and the Internet of Things

The Internet of Things (IoT) has caused a revolutionary paradigm shift in computer networking. After decades of human-centered routines, where devices were merely tools that enabled human beings to authenticate themselves and perform activities, we are now dealing with a device-centered paradigm: the devices themselves are actors, not just tools for people. Conventional identity access management (IAM) frameworks were not designed to handle the challenges of IoT. Trying to use traditional IAM systems to reconcile heterogeneous devices and complex federations of online services (e.g., IoT sensors and cloud computing solutions) adds a cumbersome architectural layer that can become hard to maintain and act as a single point of failure. In this paper, we propose UniquID, a blockchain-based solution that overcomes the need for centralized IAM architectures while providing scalability and robustness. We also present the experimental results of a proof-of-concept UniquID enrolment network, and we discuss two different use-cases that show the considerable value of a blockchain-based IAM.Comment: 15 pages, 10 figure

Probiotics for Broilers, Turkeys and Laying Hens (III)

Probiotics have been one of the latest types of feed additives to be of interest to poultry producers. They are designed to improve the birds\u27 performance by effecting a more favorable microflora in the intestinal tract. There have been numerous reports of improved rates of gain and feed utilization with broilers and turkeys and improved production and feed conversion with laying hens. Work of this type has been reported from the University of Florida, Texas A and M University and the University of Arizona

X-Ray and Infrared Enhancement of Anomalous X-ray Pulsar 1E 2259+58

The long term (~1.5 years) X-ray enhancement and the accompanying infrared enhancement light curves of the anomalous X-ray pulsar 1E 2259+58 following the major bursting epoch can be accounted for by the relaxation of a fall back disk that has been pushed back by a gamma-ray flare. The required burst energy estimated from the results of our model fits is low enough for such a burst to have remained below the detection limits. We find that an irradiated disk model with a low irradiation efficiency is in good agreement with both X-ray and infrared data. Non-irradiated disk models also give a good fit to the X-ray light curve, but are not consistent with the infrared data for the first week of the enhancement.Comment: 17 pages, 3 figures, accepted for publication in Ap

Potential of Inula racemosa root extract and its fractions to suppress root-knot nematode Meloidogyne incognita

Nematicidal potential of chloroform root extract of Inula racemosa and its fractions was investigated on egg hatching and mortality of root knot nematode Meloidogyne incognita. Egg masses and second stage juveniles (J2) of M. incognita were exposed to different concentrations (0.1-8.0 mg ml-1) of I. racemosa root extract and its fractions. Observations on egg hatch were recorded on 1st, 3rd, 5th, 7th and 9th day and those of mortality studies were recorded on 2nd, 4th, 6th, 8th and 10th day, respectively. Significant mortality as well as egg hatch inhibition was observed for all the tested components at 5 %. The root extract was found to be most effective in controlling egg hatching as complete inhibition was observed at 8.0 mg ml-1 concentration on 1stday of treatment and nonpolar fraction was most effective in causing mortality of J2 of M. incognita as 100 % inhibition was observed at 6.0 and 8.0 mg ml-1 concentration on 2nd day of treatment. Maximum inhibition of egg hatching was observed for root extract at 8.0 mg ml-1 concentration and 100 % mortality was observed for root extract as well as nonpolar fraction at the same concentration. The nonpolar fraction was most effective in causing mortality as maximum mortality was observed at 6.0 and 8.0 mg ml-1 concentration throughout the exposure time. Polar fraction was least effective among all the components both in egg hatch inhibition and J2 mortality of M. incognita. Both the activities showed concentrations as well as time dependence. Results show different role of tested components on egg hatching and mortality of root knot nematode. The root extract of I. racemosa and its fractions showed a potential to develop new nematicide

The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons.

Chronic kidney disease (CKD) is common, with hypertension and diabetes mellitus acting as major risk factors for its development. Cardiovascular disease is the leading cause of death worldwide and the most frequent end point of CKD. There is an urgent need for more precise methods to identify patients at risk of CKD and cardiovascular disease. Alterations in microvascular structure and function contribute to the development of hypertension, diabetes, CKD, and their associated cardiovascular disease. Homology between the eye and the kidney suggests that noninvasive imaging of the retinal vessels can detect these microvascular alterations to improve targeting of at-risk patients. Retinal vessel-derived metrics predict incident hypertension, diabetes, CKD, and cardiovascular disease and add to the current renal and cardiovascular risk stratification tools. The advent of optical coherence tomography (OCT) has transformed retinal imaging by capturing the chorioretinal microcirculation and its dependent tissue with near-histological resolution. In hypertension, diabetes, and CKD, OCT has revealed vessel remodeling and chorioretinal thinning. Clinical and preclinical OCT has linked retinal microvascular pathology to circulating and histological markers of injury in the kidney. The advent of OCT angiography allows contrast-free visualization of intraretinal capillary networks to potentially detect early incipient microvascular disease. Combining OCT's deep imaging with the analytical power of deep learning represents the next frontier in defining what the eye can reveal about the kidney and broader cardiovascular health

How explicit are the barriers to failure in safety arguments?

Safety cases embody arguments that demonstrate how safety properties of a system are upheld. Such cases implicitly document the barriers that must exist between hazards and vulnerable components of a system. For safety certification, it is the analysis of these barriers that provide confidence in the safety of the system. The explicit representation of hazard barriers can provide additional insight for the design and evaluation of system safety. They can be identified in a hazard analysis to allow analysts to reflect on particular design choices. Barrier existence in a live system can be mapped to abstract barrier representations to provide both verification of barrier existence and a basis for quantitative measures between the predicted barrier behaviour and performance of the actual barrier. This paper explores the first stage of this process, the binding between explicit mitigation arguments in hazard analysis and the barrier concept. Examples from the domains of computer-assisted detection in mammography and free route airspace feasibility are examined and the implications for system certification are considered

Clinical Research Environment in India: Challenges and Proposed Solutions.

India has compelling need and keen aspirations for indigenous clinical research. Notwithstanding this need and previously reported growth the expected expansion of Indian clinical research has not materialized. We reviewed the scientific literature, lay press reports, and ClinicalTrials.gov data for information and commentary on projections, progress, and impediments associated with clinical trials in India. We also propose targeted solutions to identified challenges. The Indian clinical trial sector grew by (+) 20.3% CAGR (compound annual growth rate) between 2005 and 2010 and contracted by (-) 14.6% CAGR between 2010 and 2013. Phase-1 trials grew by (+) 43.5% CAGR from 2005-2013, phase-2 trials grew by (+) 19.8% CAGR from 2005-2009 and contracted by (-) 12.6% CAGR from 2009-2013, and phase-3 trials grew by (+) 13.0% CAGR from 2005-2010 and contracted by (-) 28.8% CAGR from 2010-2013. This was associated with a slowing of the regulatory approval process, increased media coverage and activist engagement, and accelerated development of regulatory guidelines and recuperative initiatives. We propose the following as potential targets for restorative interventions: Regulatory overhaul (leadership and enforcement of regulations, resolution of ambiguity in regulations, staffing, training, guidelines, and ethical principles [e.g., compensation]).Education and training of research professionals, clinicians, and regulators.Public awareness and empowerment. After a peak in 2009-2010, the clinical research sector in India appears to be experiencing a contraction. There are indications of challenges in regulatory enforcement of guidelines; training of clinical research professionals; and awareness, participation, partnership, and the general image amongst the non-professional media and public. Preventative and corrective principles and interventions are outlined with the goal of realizing the clinical research potential in India